4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
SynBiotic SE (SBX) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Düsseldorf, Germany with about 79 employees. Its market capitalization is roughly €5 million. In the fiscal year ended 2024-12-31, SBX reported €14M in revenue and (€10M) in net income.
SynBiotic SE, together with its subsidiaries, engages in the pharmaceutical business in Germany and Europe. It is involved in the cultivation, research, development, production, and distribution of medicinal cannabis; industrial hemp; and cannabidiol and cannabinoid-based products.
Interactive charts & full statements →
| Income statement | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Revenue | €14M | €4M | €8M | €9M |
| Gross Profit | €5M | €2M | €4M | €5M |
| Operating Income (EBIT) | (€10M) | (€11M) | (€25M) | (€11M) |
| Net Income | (€10M) | (€11M) | (€24M) | (€13M) |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Assets | €46M | €35M | €41M | €61M |
| Total Liabilities | €25M | €20M | €18M | €24M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SBX viewer.
About TickerBase · Data methodology & sources · Privacy · Terms